Helen G. Mulholland
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Helen G. Mulholland has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Brian T. Johnston
6 shared publicationsDamian T. McManus
5 shared publications- Anna Gavin
Queen’s University Belfast
3 shared publications - Chris Cardwell
Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland, UK
3 shared publications - Liam Murray
Centre for Public Health, School of Medicine and Dentistry and Biomedical Science, Queen's University Belfast, Institute of Clinical Sciences, Block B, Royal Victoria Hospital, Belfast BT12 6BA, UK.u.
3 shared publications Shivaram Bhat
3 shared publications
Latest Publications
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Phase 3 Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Phase 3 Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Investigation for Biomarkers of Barrett's Esophagus
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Investigation for Biomarkers of Barrett's Esophagus
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
The Proportion of Esophageal Adenocarcinoma Patients With Prior Barrett's Esophagus: Results From a Large Population Based Cohort
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
The Proportion of Esophageal Adenocarcinoma Patients With Prior Barrett's Esophagus: Results From a Large Population Based Cohort
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5) , -2-2
13 Increasing Incidence of Barrett's Esophagus is Not Entirely Explained by Endoscopic Practice
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5) , -2-2
13 Increasing Incidence of Barrett's Esophagus is Not Entirely Explained by Endoscopic Practice
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5)
89 Low Incidence of Esophageal Adenocarcinoma in Barrett's Esophagus – Time to Rethink Surveillance Guidelines?
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5)
89 Low Incidence of Esophageal Adenocarcinoma in Barrett's Esophagus – Time to Rethink Surveillance Guidelines?
- 1 February 2009
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 89 (2) , 568-576
Glycemic index, glycemic load, and risk of digestive tract neoplasms: a systematic review and meta-analysis
Background: Habitual consumption of diets with a high glycemic index (GI) and a high glycemic load (GL) may influence cancer risk via hyperinsulinemia and the insulin-like growth factor axis.
- 1 February 2009
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 89 (2) , 568-576
Glycemic index, glycemic load, and risk of digestive tract neoplasms: a systematic review and meta-analysis
Background: Habitual consumption of diets with a high glycemic index (GI) and a high glycemic load (GL) may influence cancer risk via hyperinsulinemia and the insulin-like growth factor axis.
- Open Access
- 7 October 2008
- Published by Springer Nature in Cancer Causes & Control
- Vol. 20 (3) , 279-288
Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma
- 7 October 2008
- Published by Springer Nature in Cancer Causes & Control
- Vol. 20 (3) , 279-288
Open AccessGlycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma
- Open Access
- 26 August 2008
- Published by Springer Nature in British Journal of Cancer
- Vol. 99 (7) , 1170-1175
Dietary glycaemic index, glycaemic load and breast cancer risk: a systematic review and meta-analysis
This systematic review aimed to examine if an association exists between dietary glycaemic index (GI) and glycaemic load (GL) intake and breast cancer risk. A systematic search was conducted in Medline and Embase and identified 14 relevant studies up to May 2008. Adjusted relative risk estimates comparing breast cancer risk for the highest versus the lowest category of GI/GL intake were extracted from relevant studies and combined in meta-analyses using a random-effects model. Combined estimates from six cohort studies show non-significant increased breast cancer risks for premenopausal women (relative risk (RR) 1.14, 95% CI 0.95–1.38) and postmenopausal women (RR 1.11, 95% CI 0.99–1.25) consuming the highest versus the lowest category of GI intake. Evidence of heterogeneity hindered analyses of GL and premenopausal risk, although most studies did not observe any significant association. Pooled cohort study results indicated no association between postmenopausal risk and GL intake (RR 1.03, 95% CI 0.94–1.12). Our findings do not provide strong support of an association between dietary GI and GL and breast cancer risk.
- 26 August 2008
- Published by Springer Nature in British Journal of Cancer
- Vol. 99 (7) , 1170-1175
Open AccessDietary glycaemic index, glycaemic load and breast cancer risk: a systematic review and meta-analysis
This systematic review aimed to examine if an association exists between dietary glycaemic index (GI) and glycaemic load (GL) intake and breast cancer risk. A systematic search was conducted in Medline and Embase and identified 14 relevant studies up to May 2008. Adjusted relative risk estimates comparing breast cancer risk for the highest versus the lowest category of GI/GL intake were extracted from relevant studies and combined in meta-analyses using a random-effects model. Combined estimates from six cohort studies show non-significant increased breast cancer risks for premenopausal women (relative risk (RR) 1.14, 95% CI 0.95–1.38) and postmenopausal women (RR 1.11, 95% CI 0.99–1.25) consuming the highest versus the lowest category of GI intake. Evidence of heterogeneity hindered analyses of GL and premenopausal risk, although most studies did not observe any significant association. Pooled cohort study results indicated no association between postmenopausal risk and GL intake (RR 1.03, 95% CI 0.94–1.12). Our findings do not provide strong support of an association between dietary GI and GL and breast cancer risk.
- Open Access
- 1 August 2008
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 88 (2) , 475-476
Glycemic index, glycemic load, and chronic disease risk
We read with interest the recent meta-analysis published by Barclay et al (1) on glycemic index (GI), glycemic load (GL), and chronic disease risk. Given the recent surge in research in this area, the meta-analysis is undoubtedly addressing a timely issue; however, we have a number of concerns about the way in which this systematic review and meta-analyses were conducted.
- 1 August 2008
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 88 (2) , 475-476
Open AccessGlycemic index, glycemic load, and chronic disease risk
We read with interest the recent meta-analysis published by Barclay et al (1) on glycemic index (GI), glycemic load (GL), and chronic disease risk. Given the recent surge in research in this area, the meta-analysis is undoubtedly addressing a timely issue; however, we have a number of concerns about the way in which this systematic review and meta-analyses were conducted.
- Open Access
- 29 July 2008
- Published by Springer Nature in British Journal of Cancer
- Vol. 99 (3) , 434-441
Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis
Long-term consumption of a high glycaemic index (GI) or glycaemic load (GL) diet may lead to chronic hyperinsulinaemia, which is a potential risk factor for cancer. To date, many studies have examined the association between GI, GL and cancer risk, although results have been inconsistent, therefore our objective was to conduct a systematic review of the literature. Medline and Embase were systematically searched using terms for GI, GL and cancer to identify studies published before December 2007. Random effects meta-analyses were performed for endometrial cancer, combining maximally adjusted results that compared risk for those in the highest versus the lowest category of intake. Separate analysis examined risk by body mass index categories. Five studies examining GI and/or GL intake and endometrial cancer risk were identified. Pooled effect estimates for endometrial cancer showed an increased risk for high GL consumers (RR 1.20; 95% CI: 1.06–1.37), further elevated in obese women (RR 1.54; 95% CI: 1.18–2.03). No significant associations were observed for GI. Only two studies examined ovarian cancer and therefore no meta-analysis was performed, but results indicate positive associations for GL also. A high GL, but not a high GI, diet is positively associated with the risk of endometrial cancer, particularly among obese women.
- 29 July 2008
- Published by Springer Nature in British Journal of Cancer
- Vol. 99 (3) , 434-441
Open AccessDietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis
Long-term consumption of a high glycaemic index (GI) or glycaemic load (GL) diet may lead to chronic hyperinsulinaemia, which is a potential risk factor for cancer. To date, many studies have examined the association between GI, GL and cancer risk, although results have been inconsistent, therefore our objective was to conduct a systematic review of the literature. Medline and Embase were systematically searched using terms for GI, GL and cancer to identify studies published before December 2007. Random effects meta-analyses were performed for endometrial cancer, combining maximally adjusted results that compared risk for those in the highest versus the lowest category of intake. Separate analysis examined risk by body mass index categories. Five studies examining GI and/or GL intake and endometrial cancer risk were identified. Pooled effect estimates for endometrial cancer showed an increased risk for high GL consumers (RR 1.20; 95% CI: 1.06–1.37), further elevated in obese women (RR 1.54; 95% CI: 1.18–2.03). No significant associations were observed for GI. Only two studies examined ovarian cancer and therefore no meta-analysis was performed, but results indicate positive associations for GL also. A high GL, but not a high GI, diet is positively associated with the risk of endometrial cancer, particularly among obese women.